| Literature DB >> 17081284 |
Andrea Sackmann1, Monika Heiner, Ina Koch.
Abstract
BACKGROUND: Signal transduction pathways are usually modelled using classical quantitative methods, which are based on ordinary differential equations (ODEs). However, some difficulties are inherent in this approach. On the one hand, the kinetic parameters involved are often unknown and have to be estimated. With increasing size and complexity of signal transduction pathways, the estimation of missing kinetic data is not possible. On the other hand, ODEs based models do not support any explicit insights into possible (signal-) flows within the network. Moreover, a huge amount of qualitative data is available due to high-throughput techniques. In order to get information on the systems behaviour, qualitative analysis techniques have been developed. Applications of the known qualitative analysis methods concern mainly metabolic networks. Petri net theory provides a variety of established analysis techniques, which are also applicable to signal transduction models. In this context special properties have to be considered and new dedicated techniques have to be designed.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17081284 PMCID: PMC1686943 DOI: 10.1186/1471-2105-7-482
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Figure 1Two conjunction subnets. Two subnets representing conjunction-coupled implications, i.e., A ⇒ (B ∧ C) and (D ∧ E) ⇒ F, respectively. If there is a token on place A, the precondition A is fulfilled, and the corresponding posttransition may fire. This event will fulfil the postconditions B and C getting each a token. If there is a token on the places D and E, the preconditions D and E are fulfilled, and the corresponding posttransition may fire. This event will fulfil the postcondition F getting a token.
Figure 2Two disjunction subnets. Two subnets representing disjunction-coupled implications, i.e., G ⇒ (H ∨ I) and (J ∨ K) ⇒ L, respectively. While the subnet on the left hand side stands for an exclusive disjunction, the right-hand subnet represents an inclusive disjunction. The two posttransitions of place G are in conflict, i.e., if there is one token on place G, both its posttransitions may fire, but only one of them can actually fire. This subnet represents an exclusive disjunction. In contrast to that, the pretransitions of place L are concurrent and can fire independently from each other, if one token is in each of the places J and K. With this subnet an inclusive disjunction is represented.
Figure 3A Petri net example. A Petri net, whose places p1 and p2 form a p-invariant, representing for example a logical negation. p1 can be a condition A and p2 a condition ¬A, or vice versa, indicating two states of the system, for example an activated or deactivated protein. The place p1 carries one token to indicate in which state the system is. Transitions t3 and t4 are connected to this p-invariant by read arcs in order to hold the token on those places, which form the p-invariant.
Figure 4Case 1 using read arcs. Case 1 of using read arcs is represented. Precondition (substance) A does not lose its fulfilment (activity) by triggering the fulfilment (activation) of a condition (substance) B.
Figure 5Case 2 using read arcs. Case 2 of using read arcs is represented. Precondition (substance) C triggers several events represented by transitions, which are concurrent, i.e., independent from each other.
The t-invariants of the example in Figure 3.
| No. | Involved transitions | Minimal? | Feasible? | Composed of |
| 1. | 1, 2 | √ | √ | - |
| 2. | 3, 5 | √ | √ | - |
| 3. | 4, 6 | √ | - | - |
| 4. | 1, 2, 4, 6 | - | √ | 3+1 |
The t-invariants of the net in Figure 3 after processing them. The middle columns indicate, whether the t-invariants are minimal, i.e., non-processed and whether they are feasible. The right column indicates how the processed invariant was built.
Figure 6A subnet representing the feasibility of minimal t-invariants. The feasibility of minimal t-invariants is represented to illustrate Equation (5). Place pbelongs to a p-invariant. It is adjacent to the pretransitions t1, t2,...tand connected to the transition tby a read arc. X and Y stand for the sets of t-invariants including the pre- and the posttransitions, respectively, which are contained in the corresponding dashed rectangles. Since pdoes not carry tokens, t-invariants are not feasible if they contain transition twithout containing at least one of the transitions t1, t2,...t. Thus, the read arc has to be bridged as described in Equation (5) to get feasible t-invariants.
Figure 7The Petri net model of the mating pheromone response pathway of S. cerevisiae. The Petri net, modelling the signal transduction pathway of the mating pheromone response in S. cerevisiae. The meaning of the places is listed in Table 3 and of the transitions in Table 4. The logical nodes are coloured in grey. A logical node is identified by its name and exists in multiple copies in the net, which are logically identical. This construct is mainly used to avoid immoderate arc crossings. The transitions, which are contained in the seven MCT-sets of Table 5, are coloured differently.
The places of the model.
| ID | Place name | Biological species |
| 1 | alpha-factor | pheromone released by an MAT |
| 2 | Ste2 _receptor | mating pheromone receptor of the modelled MAT |
| 3 | receptor_ factor_complex | complex consisting of the |
| 4 | receptor_complex | the above named complex is activated by a conformation change |
| 5 | trimer_bound_to_receptor | heterotrimeric G protein, which is coupled to the Ste2 receptor |
| 6 | G_alpha_GTP | dissociated G |
| 7 | G_beta_gamma_dimer | G-protein G |
| 8 | Cdc24 | Cdc24, i.e., guanine nucleotide exchange factor of Cdc42 |
| 9 | Cdc42(at_pm) | Cdc42 located at the plasma membrane |
| 10 | Ste20 | protein kinase Ste20 |
| 11 | Ste5 (scaffold) | Ste5, acting as a scaffold protein |
| 12 | Ste5/Ste11 | protein complex consisting of Ste5 and Ste11 |
| 13 | Fus3 | MAP kinase Fus3 |
| 14 | Ste7/Fus3 | protein complex consisting of Ste7 and Fus3 |
| 15 | MAPK_complex1 | MAPK complex consisting of Ste5, Ste11, Ste7 and Fus3 |
| 16 | Ste20_at_pm | Ste20 located at the plasma membrane, i.e., near the MAPK complex |
| 17 | complex2 | as complex1, but Ste11 is activated additionally |
| 18 | complex3 | as complex2, but Ste7 is activated additionally |
| 19 | complex4 | as complex3, but Fus3 is activated additionally |
| 20 | Fus3PP | dissociated Fus3 in the activated form |
| 21 | compl_without_Fus3 | as complex4, but without Fus3 |
| 22 | repr_complex | complex containing Ste12 repressed by Fus3 or Kss1 and Dig1/Dig2 |
| 23 | Dig1/Dig2 | Ste12 inhibitors, i.e., cofactors for the repression |
| 24 | free_Ste12 | Ste12 released out of the repression complex |
| 25 | Ste12 | activated transcription factor Ste12 |
| 26 | Msg5 | phosphatase Msg5 being able to deactivate Fus3 or Kss1 |
| 27 | Fus3_dephos | deactivated Fus3 |
| 28 | other_genes | pheromone regulated genes encoding mating related cell responses |
| 29 | Bar1_in_nucleus | synthesised protease Bar1 located in the nucleus |
| 30 | Bar1 | Bar1 secreted in the cell environment |
| 31 | inact_Far1 | synthesised Far1 located in the nucleus in an inactive form |
| 32 | Far1 | Far1 activated by phosphorylation |
| 33 | Far1_in_cytosol | active Far1 located in the cytosol |
| 34 | Sst2_in_nucleus | synthesised Sst2 located in the nucleus in an inactive form |
| 35 | phos_Sst2 | Sst2 activated by phosphorylation |
| 36 | Sst2 | active Sst2 located in the cytosol |
| 37 | inact_component | complex labelled for degradation by phosphorylation |
| 38 | phos_Kss1 | MAP kinase Kss1 activated by phosphorylation |
| 39 | unphos_Kss1 | inactive Kss1 |
| 40 | Akr1 | protein Akr1 located at plasma membrane |
| 41 | Yck1/Yck2_at_pm | kinases Yck1/Yck2 being able to label the Ste2 for degradation |
| 42 | inact_receptor | receptor labelled for ubiquitination and endocytosis |
The places of the model, see Figure 7, each listed with its name, its ID and the biological species represented by this node.
The transitions of the model.
| ID | Transition name | Biological event |
| 1 | MATalpha_cell(surroundings) | a near MAT |
| 2 | binding_factor _to_receptor | the |
| 3 | receptor_synthesis | synthesis of the cell surface receptor Sst2 |
| 4 | receptor _conformation_change | conformation change of the receptor |
| 5 | division(in_alpha_subunit:GDP->GTP) | dissociation of the G |
| 6 | hydrolysis_GTP->GDP | hydrolysis reassociates G |
| 7 | interact_through_Far1 | G |
| 8 | Cdc42:GDP->GTP | Cdc24 supported activation of Cdc42 |
| 9 | active_Cdc42_constitutive_at_pm | constitutive active Cdc42 attending the processes |
| 10 | binding_to_Ste20 | G |
| 11 | Ste20_activated | Cdc42 at plasma membrane activates Ste20 |
| 12 | binding_to_Ste5 | G |
| 13 | Ste5_binds_Ste11 | Ste5 binds Ste11 |
| 14 | Fus3_synth | synthesis of kinase Fus3 |
| 15 | Fus3_binds_Ste7 | Ste7 binds Fus3 |
| 16 | complex-formation | Ste5/Ste11 binds Ste7/Fus3 |
| 17 | Ste20_phos_Ste11 | phosphorylation of Ste11 by Ste20 |
| 18 | Ste11_phos_Ste7 | phosphorylation of Ste7 by Ste11 |
| 19 | Ste7_phos_Fus3 | phosphorylation of Fus3 by Ste7 |
| 20 | Fus3PP-release | release of activated Fus3 out of the MAPK complex |
| 21 | binding_free_Fus3 | remaining MAPK complex binds Fus3 |
| 22 | Ste12_inhibit _phos | phosphorylation of Ste12 inhibitors Dig1/Dig2 by Fus3PP |
| 23 | Ste12-release | release of Ste12 out of the repression complex |
| 24 | Ste12_phos | phosphorylation of Ste12 by Fus3PP |
| 25 | transcr_activation | transcription activation of pheromone regulated genes |
| 26 | Fus3PP_dephos | dephosphorylation of Fus3PP by Msg5 |
| 27 | repression_through_Fus3 | Ste12 repression through inactive Fus3 and Dig1/Dig2 |
| 28 | cell_fusion | processes leading to the fusion of the two haploid cells |
| 29 | transport_out_of_cell | Bar1 transport into the cell environment |
| 30 | factor _destruction | Bar1 transmitted destruction of the |
| 31 | Far1_phos | phosphorylation of Far1 by Fus3PP |
| 32 | cell_cycle_arrest in_G1 | Far1 caused arrest in the cell cycle phase G1 |
| 33 | transport_out_of_nucleus | Far1 transport out of the nucleus |
| 34 | Sst2_phos | phosphorylation of Sst2 by Fus3PP |
| 35 | transport_out_of_nucleus | Sst2 transport out of the nucleus |
| 36 | accelerated_hydr_GTP->GDP | accelerated hydrolysis reassociates the G-protein |
| 37 | Ste11_neg_phos | Fus3PP labels the MAPK complex at Ste11 for degradation |
| 38 | degradation | degradation of the MAPK complex |
| 39 | Ste7_neg_phos | Fus3PP labels the MAPK complex at Ste7 for degradation |
| 40 | Ste7_phos_Kss1 | phosphorylation of Kss1 by Ste7 |
| 41 | accelerated-dephos_Kss1 | deactivation of phosphorylated Kss1 by Fus3PP |
| 42 | Kss1_dephos | dephosphorylation of phosphorylated Kss1 by Msg5 |
| 43 | repression_through_Kss1 | Ste12 repression through inactive Kss1 and Dig1/Dig2 |
| 44 | techn_input | technical: the repressed Ste12 complex assumed to be present |
| 45 | Akr1_synthesis | synthesis of Akr1 |
| 46 | Akr1_binds_Yck1/Yck2 | Akr1 binds Yck1/Yck2 |
| 47 | receptor_phos | labelling of Ste2 for degradation |
| 48 | ubiquit_endocytosis | ubiquitination and endocytosis of the receptor |
The transitions of the model, see Figure 7, each listed with its name, its ID and the biological event represented by this node.
The minimal p-invariants and their biological meaning.
| No. | Places | Biological meaning |
| 1. | 5, 7 | G |
| 2. | 5, 6 | G |
| 3. | 38, 39 | Kss1: active and inactive form |
The minimal p-invariants and their biological meaning.
The maximal common transition sets.
| MCT-set | Transitions | Biological meaning |
| 1 | 1, 2, 3, 4 | Receptor activation |
| 2 | 7, 8, 33 | Interaction G |
| 3 | 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 | MAP kinase cascade |
| 4 | 22, 23, 24 | Ste12 activation |
| 5 | 25, 28, 29, 30, 31, 34, 35, 36, 44 | Transcription of the pheromone-responding genes |
| 6 | 26, 27 | Ste12 repression through inactive Fus3 |
| 7 | 45, 46, 47, 48 | Receptor endocytosis |
Transitions grouped into maximal common transition sets over their occurrence in the same feasible t-invariants. The right column contains the biological meaning of the resulting set. Only MCT-sets with more than one transition are considered here
The t-invariants.
| No. | Involved transitions | Minimal? | Feasible? | Composed of | |
| MCT-sets | single transitions | ||||
| 1. | 1 | 5, 6 | √ | √ | - |
| 2. | 1, 7 | - | √ | √ | - |
| 3. | 3 | 37, 38 | √ | - | - |
| 4. | 3 | 38, 39 | √ | - | - |
| 5. | 3, 4 | 43 | √ | - | - |
| 6. | 3 | 40, 41 | √ | - | - |
| 7. | 1, 3, 4, 5 | 5, 32, 40, 42 | √ | √ | - |
| 8. | 1, 2, 3, 4, 5 | 5, 40, 42 | √ | √ | - |
| 9. | 1, 3, 4, 5, 6 | 5, 32 | √ | √ | - |
| 10. | 1, 2, 3, 4, 5, 6 | 5 | √ | √ | - |
| 11. | 1, 3 | 5, 6, 37, 38 | - | √ | 3 + 1 |
| 12. | 1, 3 | 5, 6, 38, 39 | - | √ | 4 + 1 |
| 13. | 1, 3, 4 | 5, 6, 43 | - | √ | 5 + 1 |
| 14. | 1, 3 | 5, 6, 40, 41 | - | √ | 6 + 1 |
The t-invariants of the net after their processing. The middle columns show, whether the invariants are minimal and/or feasible. The right column indicates how the processed invariants were built.
The biological meaning of the feasible t-invariants.
| No. | Biological meaning |
| 1. | Dissociation and reassociation of the G protein subunits |
| 2. | Endocytosis of the activated receptor |
| 7. | Changed gene transcription, cell cycle arrest, de-/phosphorylation Kss1 |
| 8. | Changed gene transcription, Far1 transport out of the nucleus, de-/phosphorylation Kss1 |
| 9. | Changed gene transcription, cell cycle arrest, repression of Ste12 through inactive Fus3 |
| 10. | Changed gene transcription, Far1 transport out of the nucleus, repression of Ste12 through inactive Fus3 |
| 11. | Signalling via the cascade, feedback degradation of Ste11 |
| 12. | Signalling via the cascade feedback degradation of Ste7 |
| 13. | Signalling via the cascade, repression of Ste12 through inactive Kss1 |
| 14. | Signalling via the cascade, phosphorylation and dephosphorylation of Kss1 |
The feasible t-invariants of Table 6 with their biological meaning. All of them involve the receptor activation, which is not explicitly mentioned, here.